Back to News

Posted
January 04, 2019

Senate approves national ‘drug czar’

In the final hours of a lame-duck Congress, lawmakers on Wednesday confirmed the Trump administration’s nominees for “drug czar” (Source: “With Senate votes, Trump gets a permanent drug czar — and his first science adviser,” Stat News, Jan. 2, 2019).

The Senate confirmed James Carroll to lead the Office of National Drug Control Policy, giving the White House a top drug policy adviser amid a national epidemic in which 70,000 Americans die each year from drug overdoses. Carroll has filled the role in an acting position since February. 

The Trump administration has identified the opioid crisis as a top priority, but had its first ONDCP nominee withdraw his nomination and has delegated much of its portfolio to Kellyanne Conway, one of the president’s top political advisers.

Attend HPIO's 2025 Health Policy Summit on Oct. 9, 2025

With limited resources and growing need, investing in policies that deliver the greatest impact is essential. This event will highlight strategies that improve health and wellbeing while reducing healthcare spending. Speakers will provide evidence-informed research responsive to today’s political climate, focusing on what works and why it matters now more than ever.

Register now